Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis

Xiaoyang Zhang, Jun Zhang, Haoran Sun, Xueling Liu, Yue Zheng, Dan Xu, Jianing Wang, Dandan Jia, Xianlin Han, Feng Liu, Jia Nie, Yuguang Shi

Research output: Contribution to journalArticle

Abstract

Background & Aims: Obesity promotes the development of nonalcoholic fatty liver diseases (NAFLDs), yet not all obese patients develop NAFLD. The underlying causes for this discrepancy remain elusive. LPGAT1 is an acyltransferase that catalyzes the remodeling of phosphatidylglycerol (PG), a mitochondrial phospholipid implicated in various metabolic diseases. Here, we investigated the role of LPGAT1 in regulating the onset of diet-induced obesity and its related hepatosteatosis because polymorphisms of the LPGAT1 gene promoter were strongly associated with susceptibility to obesity in Pima Indians. Methods: Mice with whole-body knockout of LPGAT1 were generated to investigate the role of PG remodeling in NAFLD. Results: LPGAT1 deficiency protected mice from diet-induced obesity, but led to hepatopathy, insulin resistance, and NAFLD as a consequence of oxidative stress, mitochondrial DNA depletion, and mitochondrial dysfunction. Conclusions: This study identified an unexpected role of PG remodeling in obesity, linking mitochondrial dysfunction to NAFLD.

Original languageEnglish (US)
Pages (from-to)763-781
Number of pages19
JournalCMGH
Volume7
Issue number4
DOIs
StatePublished - Jan 1 2019

Fingerprint

Phosphatidylglycerols
Obesity
Diet
Potassium Iodide
Acyltransferases
Metabolic Diseases
Mitochondrial DNA
Insulin Resistance
Phospholipids
Oxidative Stress
Non-alcoholic Fatty Liver Disease
Genes

Keywords

  • Cardiolipin
  • LPGAT1
  • MEGDEL Syndrome
  • Mitochondrial Dysfunction
  • NAFLD

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis. / Zhang, Xiaoyang; Zhang, Jun; Sun, Haoran; Liu, Xueling; Zheng, Yue; Xu, Dan; Wang, Jianing; Jia, Dandan; Han, Xianlin; Liu, Feng; Nie, Jia; Shi, Yuguang.

In: CMGH, Vol. 7, No. 4, 01.01.2019, p. 763-781.

Research output: Contribution to journalArticle

Zhang, Xiaoyang ; Zhang, Jun ; Sun, Haoran ; Liu, Xueling ; Zheng, Yue ; Xu, Dan ; Wang, Jianing ; Jia, Dandan ; Han, Xianlin ; Liu, Feng ; Nie, Jia ; Shi, Yuguang. / Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis. In: CMGH. 2019 ; Vol. 7, No. 4. pp. 763-781.
@article{0ba9f989c301448b8f0839e862375e3c,
title = "Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis",
abstract = "Background & Aims: Obesity promotes the development of nonalcoholic fatty liver diseases (NAFLDs), yet not all obese patients develop NAFLD. The underlying causes for this discrepancy remain elusive. LPGAT1 is an acyltransferase that catalyzes the remodeling of phosphatidylglycerol (PG), a mitochondrial phospholipid implicated in various metabolic diseases. Here, we investigated the role of LPGAT1 in regulating the onset of diet-induced obesity and its related hepatosteatosis because polymorphisms of the LPGAT1 gene promoter were strongly associated with susceptibility to obesity in Pima Indians. Methods: Mice with whole-body knockout of LPGAT1 were generated to investigate the role of PG remodeling in NAFLD. Results: LPGAT1 deficiency protected mice from diet-induced obesity, but led to hepatopathy, insulin resistance, and NAFLD as a consequence of oxidative stress, mitochondrial DNA depletion, and mitochondrial dysfunction. Conclusions: This study identified an unexpected role of PG remodeling in obesity, linking mitochondrial dysfunction to NAFLD.",
keywords = "Cardiolipin, LPGAT1, MEGDEL Syndrome, Mitochondrial Dysfunction, NAFLD",
author = "Xiaoyang Zhang and Jun Zhang and Haoran Sun and Xueling Liu and Yue Zheng and Dan Xu and Jianing Wang and Dandan Jia and Xianlin Han and Feng Liu and Jia Nie and Yuguang Shi",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jcmgh.2019.02.002",
language = "English (US)",
volume = "7",
pages = "763--781",
journal = "Cellular and Molecular Gastroenterology and Hepatology",
issn = "2352-345X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis

AU - Zhang, Xiaoyang

AU - Zhang, Jun

AU - Sun, Haoran

AU - Liu, Xueling

AU - Zheng, Yue

AU - Xu, Dan

AU - Wang, Jianing

AU - Jia, Dandan

AU - Han, Xianlin

AU - Liu, Feng

AU - Nie, Jia

AU - Shi, Yuguang

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background & Aims: Obesity promotes the development of nonalcoholic fatty liver diseases (NAFLDs), yet not all obese patients develop NAFLD. The underlying causes for this discrepancy remain elusive. LPGAT1 is an acyltransferase that catalyzes the remodeling of phosphatidylglycerol (PG), a mitochondrial phospholipid implicated in various metabolic diseases. Here, we investigated the role of LPGAT1 in regulating the onset of diet-induced obesity and its related hepatosteatosis because polymorphisms of the LPGAT1 gene promoter were strongly associated with susceptibility to obesity in Pima Indians. Methods: Mice with whole-body knockout of LPGAT1 were generated to investigate the role of PG remodeling in NAFLD. Results: LPGAT1 deficiency protected mice from diet-induced obesity, but led to hepatopathy, insulin resistance, and NAFLD as a consequence of oxidative stress, mitochondrial DNA depletion, and mitochondrial dysfunction. Conclusions: This study identified an unexpected role of PG remodeling in obesity, linking mitochondrial dysfunction to NAFLD.

AB - Background & Aims: Obesity promotes the development of nonalcoholic fatty liver diseases (NAFLDs), yet not all obese patients develop NAFLD. The underlying causes for this discrepancy remain elusive. LPGAT1 is an acyltransferase that catalyzes the remodeling of phosphatidylglycerol (PG), a mitochondrial phospholipid implicated in various metabolic diseases. Here, we investigated the role of LPGAT1 in regulating the onset of diet-induced obesity and its related hepatosteatosis because polymorphisms of the LPGAT1 gene promoter were strongly associated with susceptibility to obesity in Pima Indians. Methods: Mice with whole-body knockout of LPGAT1 were generated to investigate the role of PG remodeling in NAFLD. Results: LPGAT1 deficiency protected mice from diet-induced obesity, but led to hepatopathy, insulin resistance, and NAFLD as a consequence of oxidative stress, mitochondrial DNA depletion, and mitochondrial dysfunction. Conclusions: This study identified an unexpected role of PG remodeling in obesity, linking mitochondrial dysfunction to NAFLD.

KW - Cardiolipin

KW - LPGAT1

KW - MEGDEL Syndrome

KW - Mitochondrial Dysfunction

KW - NAFLD

UR - http://www.scopus.com/inward/record.url?scp=85064267997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064267997&partnerID=8YFLogxK

U2 - 10.1016/j.jcmgh.2019.02.002

DO - 10.1016/j.jcmgh.2019.02.002

M3 - Article

C2 - 30831319

AN - SCOPUS:85064267997

VL - 7

SP - 763

EP - 781

JO - Cellular and Molecular Gastroenterology and Hepatology

JF - Cellular and Molecular Gastroenterology and Hepatology

SN - 2352-345X

IS - 4

ER -